InVitro International: The Irvine developer of toxicity...
- Share via
InVitro International: The Irvine developer of toxicity tests reported a loss of $727,191, or 12 cents a share, for its latest fiscal quarter. That compared to a loss of $861,295, or 17 cents a share, for the same period a year earlier. Revenue for the company’s first fiscal quarter, which ended Dec. 31, increased 30%, to $343,809 from $264,136.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
